Core Insights - Mindray Medical has demonstrated resilience in the global healthcare industry with a "double growth" report for 2024, achieving revenue of 36.726 billion yuan, a year-on-year increase of 5.14%, and a net profit of 11.668 billion yuan, up 0.74% [1] - Since its IPO in 2018, Mindray has maintained seven consecutive years of revenue and net profit growth, with revenue increasing 2.2 times and net profit rising 1.5 times over the past five years [1] - The demand for quality healthcare resources is increasing globally due to ongoing economic growth and an aging population, which Mindray has capitalized on [1] Revenue Performance - In 2024, Mindray's overseas business performed exceptionally well, generating revenue of 16.434 billion yuan, a growth of 21.28%, accounting for 44.75% of total revenue [1] - Revenue from developing countries reached 10.910 billion yuan, marking a year-on-year increase of 24.59%, serving as a significant driver for overall performance [1] Strategic Initiatives - Mindray's success in the global market is attributed to its digital intelligence strategy, which has established a smart medical ecosystem and penetrated high-end customer segments [1] - The company has covered 80 out of the top 100 hospitals globally as ranked by Newsweek, showcasing its competitive capability against leading international medical device firms [1] Human Capital Efficiency - According to Haitong Securities, Mindray's per capita revenue in 2023 reached $270,000, surpassing Siemens' $260,000, while its per capita profit was $90,000, higher than Medtronic, Abbott, and Danaher [2] High-End Product Launches - Mindray has introduced several high-end products, including the Nuewa A20 ultrasound and the new generation BeneHeart R series ECG machine, which feature intelligent diagnostic assistance [2] - The company also launched the world's first clinical-grade critical care medical model, "Qiyuan," which supports critical knowledge queries, condition Q&A, suggestion generation, and medical record writing [2] Addressing Global Healthcare Challenges - Mindray's digital intelligence solutions aim to address the scarcity of quality medical resources and healthcare professionals, enhancing diagnostic efficiency and reducing costs [3] - The chairman of Mindray, Li Xiting, emphasized the company's commitment to leveraging digital intelligence to represent Chinese medical strength and contribute to global healthcare equity [3]

报名：首届全球眼科大会 | 议程更新 那么，本次 医学影像展区 都将展出哪些创新产品呢？一起来看看吧！ # GE医疗 展位 ：3R13 展品 ： "英雄"磁共振结合"Sonic深度学习平台" GE医疗 是一家全球领先的医疗科技、诊断药物和数字化解决方案的创新企业，致力于通过整合解决方案和服 务提升医疗效率和精准度。公司业务遍及 160多个国家和地区 ，年营收超196亿美元，拥有全球员工51,000 名。 GE医疗的 SIGNA Hero磁共振设备通过搭载人工智能深度学习Sonic平台 ，实现了"脑心同治"理念的落地。该 设备将传统超过一小时的检查时间缩短至半小时，仅需一次造影剂注射即可完成脑心联合评估，大幅提升检查 效率和成功率。此外，SIGNA Hero还具备 高分辨斑块成像功能 ，能够评估缺血性脑卒中和心脏病风险，为不 明原因卒中患者提供全面诊断信息。 基于SIGNA Hero的脑心同治及肿瘤精准诊疗应用方案已入选《2024年高端医疗装备推广应用项目》，并由天 津医科大学总医院牵头，联合多家医院进行临床应用研究。 # 飞利浦医疗 报名：首届全球骨科大会 | 议程更新 报名：首届全球心血管大会 | 奖项申报 ...

报名：首届全球眼科大会 | 议程更新 报名：首届全球心血管大会 | 奖项申报 报名：首届全球骨科大会 | 奖项评选 合作伙伴征集：2025全球手术机器人大会 2025年4月8日至11日， 第91届中国国际医疗器械（春季）博览会（CMEF） 将在上海国家会展中心拉开帷幕。作为亚太地区规模最大的医疗科技展会，CMEF始终 是行业风向标，不仅汇聚全球创新技术，更见证着产业发展的新趋势。本届展会预计吸引 全球30多个国家和地区的近 5000家 企业，携 数万款 前沿产品集中亮相 ，以"创新科技，智领未来"为主题，共同探讨医疗科技的突破与未来。 CMEF不仅是一场产品与技术的集中展示，更是医疗行业生态的一次深度联动。从人工智能驱动的医学影像，到手术机器人赋能精准医疗，从智慧医院建设，到国 产医疗设备的崛起，CMEF2025通过高规格论坛、产业对话和技术展示，构建起全方位的交流平台，为行业发展提供新的思路与动能。 在这一医疗科技的年度盛会上，哪些企业将携最新技术亮相？哪些创新产品值得重点关注？ 思宇梳理了本届CMEF的亮点企业，一起来看它们如何在这场科技盛宴 中抢占先机！ P.S. 展位图附于文末，感兴趣的读者可按图索骥 ...